QT VASCULAR said that the clinical trial for its Chocolate® Touch drug-coated balloon in Europe and New Zealand has "substantially exceeded" its patient enrolment goal for Q4 2014. The company expects to obtain CE...
Register to read this article. Log in if you are already a subscriber.Register to read this article. Log in if you are already a subscriber.Please log in or subscribe to continue reading.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes